GB201721259D0 - Bicyclic peptide ligands specific for EphA2 - Google Patents
Bicyclic peptide ligands specific for EphA2Info
- Publication number
- GB201721259D0 GB201721259D0 GBGB1721259.8A GB201721259A GB201721259D0 GB 201721259 D0 GB201721259 D0 GB 201721259D0 GB 201721259 A GB201721259 A GB 201721259A GB 201721259 D0 GB201721259 D0 GB 201721259D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- epha2
- peptide ligands
- ligands specific
- bicyclic peptide
- bicyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000051096 EphA2 Receptor Human genes 0.000 title 1
- 108010055196 EphA2 Receptor Proteins 0.000 title 1
- 125000002619 bicyclic group Chemical group 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Priority Applications (40)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1721259.8A GB201721259D0 (en) | 2017-12-19 | 2017-12-19 | Bicyclic peptide ligands specific for EphA2 |
TW107144453A TWI825046B (en) | 2017-12-19 | 2018-12-11 | Bicyclic peptide ligands specific for epha2 |
US16/220,685 US11484602B2 (en) | 2017-12-19 | 2018-12-14 | Bicyclic peptide ligands specific for EphA2 |
ARP180103703A AR113966A1 (en) | 2017-12-19 | 2018-12-18 | EphA2 SPECIFIC BICYCLIC PEPTIDES LIGANDS |
CA3086257A CA3086257A1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
BR112020012349-8A BR112020012349A2 (en) | 2017-12-19 | 2018-12-19 | epha2-specific bicyclic peptide ligands |
EP18829926.7A EP3727461A1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
DK18829437.5T DK3727460T3 (en) | 2017-12-19 | 2018-12-19 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 |
LTEPPCT/GB2018/053675T LT3727460T (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
PL18829437.5T PL3727460T3 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
MX2020006482A MX2020006482A (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2. |
AU2018387417A AU2018387417B2 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for EphA2 |
ES18829437T ES2922632T3 (en) | 2017-12-19 | 2018-12-19 | EphA2-specific bicyclic peptide ligands |
SG11202005494QA SG11202005494QA (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
KR1020207019675A KR20200105839A (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligand specific for EphA2 |
EP18829437.5A EP3727460B1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
EP22161978.6A EP4053145A1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
MX2020006474A MX2020006474A (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2. |
BR112020012246-7A BR112020012246A2 (en) | 2017-12-19 | 2018-12-19 | epha2-specific bicyclic peptide ligands |
AU2018387418A AU2018387418B2 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for EphA2 |
PCT/GB2018/053678 WO2019122863A1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
SG11202005495UA SG11202005495UA (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
PCT/GB2018/053675 WO2019122860A1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
JP2020534623A JP7293231B2 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for EphA2 |
IL275440A IL275440B2 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
CN201880089662.7A CN111787955A (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for EphA2 |
US16/771,186 US11696956B2 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for EphA2 |
SI201830718T SI3727460T1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
CN201880089757.9A CN111741771A (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for EPHA2 |
PT188294375T PT3727460T (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
KR1020207019676A KR20200105840A (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligand specific for EphA2 |
HUE18829437A HUE059126T2 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
HRP20220871TT HRP20220871T1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
CA3085253A CA3085253A1 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligands specific for epha2 |
JP2020534361A JP7404241B2 (en) | 2017-12-19 | 2018-12-19 | Bicyclic peptide ligand specific for EphA2 |
PH12020550929A PH12020550929A1 (en) | 2017-12-19 | 2020-06-17 | Bicyclic peptide ligands specific for epha2 |
IL275437A IL275437A (en) | 2017-12-19 | 2020-06-17 | Bicyclic peptide ligands specific for epha2 |
US17/934,896 US11833211B2 (en) | 2017-12-19 | 2022-09-23 | Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2 |
US18/313,983 US20240000957A1 (en) | 2017-12-19 | 2023-05-08 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 |
JP2023093890A JP2023130345A (en) | 2017-12-19 | 2023-06-07 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1721259.8A GB201721259D0 (en) | 2017-12-19 | 2017-12-19 | Bicyclic peptide ligands specific for EphA2 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201721259D0 true GB201721259D0 (en) | 2018-01-31 |
Family
ID=61008664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1721259.8A Ceased GB201721259D0 (en) | 2017-12-19 | 2017-12-19 | Bicyclic peptide ligands specific for EphA2 |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR113966A1 (en) |
GB (1) | GB201721259D0 (en) |
-
2017
- 2017-12-19 GB GBGB1721259.8A patent/GB201721259D0/en not_active Ceased
-
2018
- 2018-12-18 AR ARP180103703A patent/AR113966A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR113966A1 (en) | 2020-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275437A (en) | Bicyclic peptide ligands specific for epha2 | |
ZA202100442B (en) | Bicyclic peptide ligands specific for nectin-4 | |
GB201721265D0 (en) | Bicyclic peptide ligands specific for EphA2 | |
GB201820316D0 (en) | Bicyclic peptide ligands specific for IL-17 | |
GB201820320D0 (en) | Bicyclic peptide ligands specific for FAPalpha | |
GB201721259D0 (en) | Bicyclic peptide ligands specific for EphA2 | |
GB201707734D0 (en) | Bicyclic peptide ligands specific for EphA2 | |
GB201818603D0 (en) | Bicyclic peptide ligands specific for epha2 | |
GB201720934D0 (en) | Bicyclic peptide ligands specific for FAPalpha | |
GB201712693D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
GB201818499D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
GB201815684D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
GB201720941D0 (en) | Bicyclic peptide ligands specific for EPHA3 | |
GB201720932D0 (en) | Bicyclic peptide ligands specific for IL-17 | |
GB201810321D0 (en) | Peptide ligands for bindingto EphA2 | |
GB201720928D0 (en) | Bicyclic peptide ligands specific for IL-6 | |
GB201621574D0 (en) | Bicyclic peptide ligands specific for fapalpha | |
GB201720933D0 (en) | Bicyclic peptide ligands specific for cathepsin G | |
GB201720940D0 (en) | Bicyclic peptide ligands specific for PSMA | |
GB201701834D0 (en) | Bicyclic peptide ligands specific for CD38 | |
GB201715621D0 (en) | Bicycle peptide ligands specific for EphA2 | |
GB201720926D0 (en) | Bicyclic peptide ligands specific for chymase | |
GB201720939D0 (en) | Bicyclic peptide ligands specific for VEGF | |
GB201720936D0 (en) | Bicyclic peptide ligands specific for TGFbeta | |
GB201712589D0 (en) | Bicyclic peptide ligands specific for CD137 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
COOA | Change in applicant's name or ownership of the application |
Owner name: BICYCLETX LIMITED Free format text: FORMER OWNER: BICYCLERD LIMITED |
|
AT | Applications terminated before publication under section 16(1) |